•
Sep 30, 2020

Seres Therapeutics Q3 2020 Earnings Report

Total Revenue
$1.42M
Previous year: $7.03M
-79.8%
EPS
-$0.36
Previous year: -$0.23
+56.5%
Gross Profit
-$22.4M
Cash and Equivalents
$207M
Free Cash Flow
-$25.9M
Total Assets
$356M

Seres Therapeutics

Seres Therapeutics